Tasca, Paola
van den Berg, Bernard M.
Rabelink, Ton J. http://orcid.org/0000-0001-6780-5186
Wang, Gangqi
Heijs, Bram
van Kooten, Cees
de Vries, Aiko P. J. http://orcid.org/0000-0002-9284-3595
Kers, Jesper http://orcid.org/0000-0002-2418-5279
Article History
Accepted: 6 June 2024
First Online: 4 July 2024
Competing interests
: J.K. is a consultant for Aiosyn B.V. and Alentis Pharmaceuticals AG, coordinates a central biopsy review commission (SIRIUS-LN trial) for Novartis AG and receives speaker fees from Chiesi pharma. B.H. is employed by Bruker Daltonics GmbH & Co. KG, which is a vendor of analytical equipment and associated software. The other authors declare no competing interests.